GSK's Zeffix slows liver cirrhotic progress.

Published: 2003-11-14 06:56:00

Updated: 2003-11-14 06:56:00

A sustained medication of GSK's Zeffix may significantly slow the progress of liver diseases complicated with a chronic "B" virus hepatitis, a researcher reported recently at the 54th annual conference of the American Society of Liver

Dr. Liau Yoon, internist of Changkoong Memorial University hospital, quoted the double blind study results of CALM (Cirrhotic Asia Pacific, Lamivudine, Multi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.